ウェビナー
Croda Pharmaのウェビナーをこちらのページでご登録ください。
当社の技術開発チームが医薬品添加剤に関するすべてが揃っていますので、お客様のニーズに応える豊富な知識とインサイトが必ず見つかります。
Virodex™:Triton™ X-100の使用禁止に対応する革新的なソリューションを模索
ウェビナー
Triton™ X-100は幅広く使用されている非イオン性界面活性剤および乳化剤ですが、その有害な環境影響のため、2021年1月よりヨーロッパで使用禁止(例外あり)となりました。この問題の対策として、クローダはVirodex™製品シリーズをご紹介します。クローダのVirodex™製品シリーズは、ウイルス不活化用および細胞溶解用として、REACH準拠、公定書準拠、cGMP EXCiPACT製造の持続可能な化学物質であり、組換えタンパク質、血液分画製品、ウイルスタンパク質、AAVといったウイルスベクターなど、バイオ製造産業での使用に最適化されています。
製品、アプリケーション、技術について詳しく見る
すべてのウェビナーにアクセスするには、まず
フィルター
45 分
Tendencias e ingredientes clave para formulaciones en la industria veterinaria
9 9 2021 | スペイン語
Summary
Os invitamos a nuestro primer webinar de Veterinaria de Croda Health Care donde hablaremos sobre:
Cómo es el mercado veterinario hoy
Tendencias actuales del mercado
Casos de estudio
El mercado de las vacunas veterinarias
Soluciones a los desafíos de formulación
El mercado de los caballos
¡y más!
Únete a nuestra especialista local Anna Homs para una sesión informativa. Por favor, consúltanos para cualquier duda y te ayudaremos.
75 分
Pharma Talks: Impactos de la Guía de Excipientes IPEC 2020 en la Optimización de Formulaciones Farmacéuticas
13 8 2021 | スペイン語
Invitamos a todos los profesionales de la industria farmacéutica a participar de nuestro primer Pharma Talks – Latinoamérica, en el mismo no solo presentaremos la nueva guía de excipientes IPEC 2020 sino también sus impactos en la agilidad del diseño de formulaciones farmacéuticas; reforzando el concepto de la herramienta de Quality by Design y su importancia en la calidad y eficacia en el desarrollo de proyectos.
75 分
Pharma Talks: Estratégias de Desenvolvimento de Formulações Lipídicas
20 7 2021 | ポルトガル語
É com grande satisfação que convidamos os profissionais da indústria farmacêutica a participarem dessa nova edição onde vamos apresentar a estratégia de Design of Experiments, através de estudos de caso de formulações lipídicas empregando o planejamento univariado e de misturas.
75 分
Pharma Talks: Impactos do Guia de Excipientes IPEC 2020 no Planejamento de Experimentos para a Indústria Farmacêutica
14 4 2021 | ポルトガル語
É com grande satisfação que convidamos os profissionais da indústria farmacêutica a participarem da nossa Live onde vamos atualizá-los sobre o novo guia IPEC 2020 para excipientes e também seus impactos no planejamento de experimentos para o desenvolvimento de novos produtos.
50 分
Croda's Commitment to Quality Standards
12 4 2021 | 英語
Learn about the implications of various news, events and trends on pharmaceutical regulations and quality requirements, like nitrosamine regulations, Brexit impacts, and more.
61 分
Roundtable: General Quality Trends in Health Care
3 2 2021 | 英語
The global environment and regulations around quality are constantly changing and can have a profound effect on drug and excipient manufacturers. Tune in to our roundtable, where perspectives from EXCiPACT, IPEC, and the USP come together to have a meaningful discussion about how these trends affect customers and manufacturers, both in the near and distant future.
59 分
Polysorbates in Biopharma Formulations
3 2 2021 | 英語
Polysorbates are a key ingredient of interest in various kinds of therapeutic areas, particularly in the realm of biopharmaceuticals. Come and learn about the role that polysorbates play in biopharma, the potential issues, and our solutions to those issues.
30 分
New Product Overview of Super Refined™ Excipients
3 2 2021 | 英語
Explore the new additions to our highly purified excipients portfolio!
49 分
New and Relevant Updates to the USP
3 2 2021 | 英語
Engagement with the various regulatory bodies within pharmaceuticals is one of the keys to ensuring that a quality product is provided to a customer. Learn from two of our in-house Croda experts on Croda's proactive and reactive approach to working with the USP.
68 分
Keynote: The Future for Excipient GMP and Regulations
3 2 2021 | 英語
The regulatory landscape surrounding excipients is rapidly changing, with a larger emphasis on patient safety, quality by design, supply chain security and an ever-growing demand for more information on things like excipient composition. Dave Schoneker speaks to some of the realities and current regulatory trends within the realm of pharmaceutical excipients and their implications within both the near and distant future. The information and controls needed are not solely the task of an individual company or manufacturer, but must be based on a collaboration between the regulatory bodies, drug manufacturers, and pharmaceutical excipient suppliers/distributors. Improved communication throughout the supply chain and regulatory community regarding how excipients are used will be critically important going forward. Tune in for an expert’s opinion on the matter.
49 分
High Purity QS-21 for High-Value Vaccines
3 2 2021 | 英語
Come and learn about one of Croda's newest offerings into the vaccine adjuvant space, QS-21, and how it can be utilised for sensitive vaccine applications.
50 分
Establishing Footprints in Asia Pacific
3 2 2021 | 英語
Learn about how Croda is working with customers in the Asia Pacific region, providing solutions to the needs of an eclectic region with new and exciting developments!
35 分
Effect of Super Refined™ Ingredients on Vitamin Stability
3 2 2021 | 英語
Vitamin stability is a key concern for the pharmaceutical and nutraceutical markets, with issues such as inherent and oxidative instability. See the benefits of our Super Refined™ products and how they can be used to minimise vitamin degradation.
35 分
Approach to Quality at Croda
3 2 2021 | 英語
A sound quality system extends beyond testing the final product before release; it manifests itself in every key step of development. Learn about Croda's approach to quality, from R&D all the way through to full scale manufacture.
44 分
The Importance of High Purity Excipients in Pharmaceutical Development Through Quality by Design
2 2 2021 | 英語
Quality by Design (QbD) is an integral part of the pharmaceutical lifecycle. Learn about how Croda works with our customers to navigate this process and ensures a high quality product every time!
60 分
Roundtable: Croda's Commitment to Quality
2 2 2021 | 英語
Quality is not just a step in our process; it is a multifaceted approach to the way we do business. Listen in on and engage in the discussion between various in-house stakeholders on the importance of quality and how we ensure that our products are made consistently and efficiently to ensure that customer needs are met.
46 分
Reduce Costs & Secure Quality with Croda's Multi-Site EXCiPACT Certifications
2 2 2021 | 英語
Come and learn about what the EXCiPACT certification is all about, and what it promises to our customers: a consistent, reliable, and high quality product every time!
65 分
Quality by Consistency: A Croda Mill Hall Perspective
2 2 2021 | 英語
Batch-to-batch consistency is not just a manufacturing requirement from us; it is a value we bring to our customers, ensuring that we give you the product you need every time. Learn about how Croda ensures batch-to-batch consistency when manufacturing our high purity ingredients.
24 分
Innovation via Collaboration: High Purity Solutions for Challenging Quality Demands
2 2 2021 | 英語
Innovation through collaboration! Come and learn about how Croda works with our customers to bring new and innovative solutions to the market.
40 分
Breadth of Quality: Site Capabilities & Overview
2 2 2021 | 英語
Croda has a wide variety of offerings, from highly purified pharmaceutical excipients, to sterile and aseptically filled vaccine adjuvants, to tailor-made EPA and DHA Omega-3 as active pharmaceutical ingredients. Come and see how we can help you do what you need to do!